Lisa Salberg and Dr. Martin Maron explore how extended heart monitoring is uncovering arrhythmias that may go undetected during traditional short-term monitoring. They also discuss A-Fib, today’s options for treating obstruction and emerging research targeting fibrosis in HCM.

Conversation recorded Sept. 11, 2026

Lisa Salberg and Dr. Anjali Owens break down promising new clinical trial results for EDG-7500, an investigational therapy for both obstructive and nonobstructive HCM. They explain how the drug may improve symptoms and heart relaxation while potentially offering a different safety and monitoring profile from current targeted therapies.

Conversation recorded Sept. 4, 2026.

Lisa Salberg and Dr. Harry Lever explore atrial fibrillation in HCM, from recognizing risk and monitoring heart rhythms to medications, cardioversion and evolving treatment options. They also discuss generic drug quality, emerging HCM therapies and how decades of progress are giving patients more tools than ever before.

Conversation was recorded on Sept. 4, 2026.

Live from ESC in Munich, Lisa Salberg and Dr. Martin Maron unpack groundbreaking results from the ACACIA-HCM trial and what they could mean for people with nonobstructive HCM. They discuss improvements in symptoms and exercise capacity, potential changes in heart structure, and a possible path toward a long-awaited new treatment option.

Lisa Salberg and Dr. Michael Ayres discuss how patients and families can recognize changing HCM symptoms and know when to call their care team or seek urgent help. They also tackle back-to-school planning, beta blockers, cardiac scarring, autonomic symptoms and the changing HCM treatment toolbox.

Conversation recorded Aug. 21, 2026

Lisa Salberg and Dr. Martin Maron take a fresh look at the long-standing role of beta blockers in HCM and how newer myosin inhibitors are changing the treatment conversation. They also discuss upcoming clinical data, fibrosis, symptom changes, and how patients can better navigate evolving care.

This conversation was recorded Aug. 14, 2026

Lisa Salberg and Dr. Alex de Feria explore the growing HCM treatment toolbox, including the innovative SESAME procedure, emerging clinical trials and new possibilities for patients. They also tackle back-to-school planning, hydration, exercise, fatigue and helping children navigate life with HCM.

This conversation was recorded August 6, 2026.

Lisa Salberg and Dr. Martin Maron explore new directions in HCM care, including emerging therapies targeting cardiac fibrosis and what researchers are learning about scarring in the heart. They also look ahead to new clinical trial data and answer patient questions about imaging, arrhythmias and the future of HCM treatment.

This conversation was recorded July 24, 2026

Lisa Salberg sits down with whistleblower Dinesh Thaker to examine the hidden risks within the generic drug supply chain and why stronger oversight is urgently needed. Together, they discuss drug quality, patient safety, and how advocacy can help drive meaningful change in the healthcare system.

This conversation was recorded June 17, 2026.

Lisa Salberg and Dr. Steve Ommen discuss practical ways to stay healthy with HCM during the busy summer months. They also break down promising new drug research, explain what emerging biomarkers mean for patients, and share why planning ahead can help people with HCM enjoy life with greater confidence.

This conversation was recorded June 19, 2026.